Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice.
about
Immunotherapy of systemic sclerosisImmune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experienceThe tyrphostin agent AG490 prevents and reverses type 1 diabetes in NOD miceImmune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD MiceMetabolic abnormalities in the pathogenesis of type 1 diabetes.Efforts to prevent and halt autoimmune beta cell destruction.Use of nonobese diabetic mice to understand human type 1 diabetesA novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice.Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials.Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man.The pancreas in human type 1 diabetes.Anti-thymocyte globulin (ATG) differentially depletes naïve and memory T cells and permits memory-type regulatory T cells in nonobese diabetic mice.PD-L1-driven tolerance protects neurogenin3-induced islet neogenesis to reverse established type 1 diabetes in NOD mice.Stimulating IL-13 receptors on T cells: a new pathway for tolerance induction in diabetes?Immune therapy for treating type 1 diabetes: challenging existing paradigms.Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes.Loss of intra-islet CD20 expression may complicate efficacy of B-cell-directed type 1 diabetes therapiesAutologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve C-peptideCombination Therapy Reverses Hyperglycemia in NOD Mice With Established Type 1 Diabetes.Acute Versus Progressive Onset of Diabetes in NOD Mice: Potential Implications for Therapeutic Interventions in Type 1 DiabetesDevelopment of standardized insulin treatment protocols for spontaneous rodent models of type 1 diabetes.Strategies to target long-lived plasma cells for treating hemophilia A inhibitors.The granulocyte colony stimulating factor pathway regulates autoantibody production in a murine induced model of systemic lupus erythematosus.Comparative genetics: synergizing human and NOD mouse studies for identifying genetic causation of type 1 diabetesIslet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcomeAutologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with Type 1 diabetes.Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.Type 1 diabetes: etiology, immunology, and therapeutic strategies.Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.Autologous regulatory T cells for the treatment of type 1 diabetes.Reestablishing T Cell Tolerance by Antibody-Based Therapy in Type 1 Diabetes.Less is more: the detrimental consequences of immunosuppressive therapy in the treatment of type-1 diabetes.Combinatorial drug delivery approaches for immunomodulation.Suppression of islet homeostasis protein thwarts diabetes mellitus progression.Adoptive T Regulatory Cell Therapy for Tolerance Induction.Deletion of the Men1 gene prevents streptozotocin-induced hyperglycemia in mice.Simultaneous Recognition of Allogeneic MHC and Cognate Autoantigen by Autoreactive T Cells in Transplant Rejection.Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes.Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA in New-Onset Type 1 DiabetesTherapies to Suppress β Cell Autoimmunity in Type 1 Diabetes
P2860
Q24634395-4EA7B275-A60C-4C2E-B105-B056098B09E5Q26850621-980000DE-2F09-44D4-BB5E-2D2857F7E351Q28483660-5E2B0C65-DD3F-4467-9115-5689320A8033Q28551036-F0F1888C-D63C-42CD-ABE4-336843F2CF61Q33940335-036CF4D4-91F7-4F12-8C2D-51495AE11819Q34077363-83248A35-1D17-4D1D-90F5-D3C9BB1BD7AAQ34078163-BC2560BB-97CA-4DA3-BCBD-714DF7434D76Q34082857-6A5FC655-C7F2-486F-BE50-10FEC4BAAB22Q34318993-373C94B3-A07C-4F9A-9137-E06C2FC9FB4CQ34448607-BAC33DC8-3F24-4BC4-B8DE-87A01C43E69BQ34496850-FBEBE20D-3931-4587-AF90-EF4A621F86BFQ34511576-C4A46A1D-21F5-41AC-9A9A-15023EF40488Q35004384-0A3B3112-7C84-44F9-898C-3E1C9EEC35E9Q35043465-8B36CB35-0E4C-4C9C-8596-F49C3F19FC58Q35242386-5E90E34E-FBF6-49DC-BA0A-51784F00CDBAQ35242428-4C4DDD44-9F45-421E-AE94-EC1AA89D8E8EQ35405281-CC2D6E9F-811A-417F-A1FF-EF5778D17FE8Q35563587-3C90338E-930F-4C5F-8ACF-3B3E67C155D0Q36186226-B42E5374-7E7C-4BA9-B73C-7F2DFC11B430Q36186271-38BB352B-A9B4-4F9C-A732-FDE55C0AC806Q36321376-5D46FEA3-19FA-49D5-A443-CE8EF9EA1D91Q36832899-D4B49E88-174C-4F2F-AB8C-A4375BAB3531Q36903222-A08F0CC3-0B8D-46E1-9301-CB8372108B26Q37088185-DB4D9814-A3F3-40A2-96B2-87E5020D7A89Q37088225-4D75079F-8491-4D8C-B2E9-305CE8E46393Q37367372-745F9287-7206-4737-AC05-9FC868C4FA0CQ37737987-86D1CBBD-81AB-4E38-B26E-0E4886446836Q37830198-9058412B-B902-490E-B280-C5C042E572A5Q37883029-F345E0C7-4F7D-4D82-8D06-729F4F3399A6Q38030480-E278FA34-754F-4EB8-A9E6-80EC7800F520Q38384138-24266B41-5D09-4E4B-8A46-31A0A61FFED2Q38385236-56B3E42A-45E6-431B-97F2-69456D939834Q38680602-3DA515EF-7BD5-400A-B06E-40A1534B6BFFQ38715653-41BE45BA-2894-4611-BFF6-3F4F2F496FEBQ40132561-AA85CACB-A823-469D-8FFC-24D2351F3308Q42086741-296D6F61-0C30-425A-B7C2-54F16887568BQ48293644-CBA64B20-97FA-4867-BF1A-DCE7C274FF95Q50702410-9E038805-6E22-4F22-9EA0-4F1B10BA8BB8Q57163295-28A406CB-5F0B-412F-BCCD-7A2BDB5CB10EQ58773667-8B6C3283-CFB6-4E9E-9E10-6874A9DE5A7B
P2860
Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immune depletion with cellular ...... tes in nonobese diabetic mice.
@en
Immune depletion with cellular ...... tes in nonobese diabetic mice.
@nl
type
label
Immune depletion with cellular ...... tes in nonobese diabetic mice.
@en
Immune depletion with cellular ...... tes in nonobese diabetic mice.
@nl
prefLabel
Immune depletion with cellular ...... tes in nonobese diabetic mice.
@en
Immune depletion with cellular ...... tes in nonobese diabetic mice.
@nl
P2093
P2860
P50
P356
P1433
P1476
Immune depletion with cellular ...... tes in nonobese diabetic mice.
@en
P2093
Clayton E Mathews
Desmond A Schatz
John J Alexander
John Williams
Mark A Atkinson
Matthew J Parker
Michael J Haller
Misty Troutt
Scott Eisenbeis
Sihong Song
P2860
P304
P356
10.2337/DB09-0557
P407
P577
2009-07-23T00:00:00Z